Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2003 May;52(5):771.
doi: 10.1136/gut.52.5.771.

Which 5-ASA?

J C Mansfield
Comment

Which 5-ASA?

J C Mansfield. Gut. 2003 May.
No abstract available

PubMed Disclaimer

Comment on

  • Which 5-ASA?
    Travis SP. Travis SP. Gut. 2002 Oct;51(4):548-9. doi: 10.1136/gut.51.4.548. Gut. 2002. PMID: 12235078 Free PMC article. No abstract available.

References

    1. Kruis W, Schreiber S, Theuer D, et al. Low does balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3 g twice daily) was superior in preventing relapses. Gut 2001;49:783–9. - PMC - PubMed
    1. Hussain FN, Ajjan RA, Riley SA. Dose loading with delayed release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters. Br J Clin Pharmacol 2000;49:323–30. - PMC - PubMed
    1. Hanauer S, Schwartz J, Robinson M, et al. Mesalamine capsules for treatment of active ulcerative colitis: Results of a controlled trial. Am J Gastroenterol 1993;88:1188–97. - PubMed
    1. Green JRB, Lobo AJ, Holdsworth CD, et al. Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. Gastroenterology 1998;114:15–22. - PubMed
    1. Levine DS, Riff DS, Pruitt R, et al. A randomized double blind dose response comparison of balsalazide 6.75g, balsalazide 2.25g and mesalamine 2.4g in the treatment of active mild-to-moderate ulcerative colitis. Am J Gastroenterol 2002;97:1398–407. - PubMed

MeSH terms